CNCE
Concert Pharmaceuticals, Inc.
CNCE
CNCE
Delisted
CNCE was delisted on the 3rd of March, 2023.
85 hedge funds and large institutions have $239M invested in Concert Pharmaceuticals, Inc. in 2017 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 25 increasing their positions, 28 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
85
Holders Change
-4
Holders Change %
-4.49%
% of All Funds
2.12%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.07%
New
21
Increased
25
Reduced
28
Closed
20
Calls
$879K
Puts
$788K
Net Calls
+$91K
Net Calls Change
-$19K
Top Buyers
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$37.5M |
| 2 |
BlackRock
New York
|
+$18.9M |
| 3 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$7.35M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$6.59M |
| 5 |
D.E. Shaw & Co
New York
|
+$4.01M |
Top Sellers
| 1 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$6.96M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$5.54M |
| 3 |
BI
BVF Inc
San Francisco,
California
|
-$4.77M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$2.63M |
| 5 |
NC
Nexthera Capital
New York
|
-$1.73M |
